Terms: = Gastric cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
37 results:
1. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
2. Expression characteristics of peripheral lymphocyte programmed death 1 and foxp3
Li H; Cao GM; Gu GL; Li SY; Yan Y; Fu Z; Du XH
World J Gastroenterol; 2023 Oct; 29(40):5582-5592. PubMed ID: 37970473
[TBL] [Abstract] [Full Text] [Related]
3. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
Xu D; Liu X; Ke S; Guo Y; Zhu C; Cao H
BMC Cancer; 2023 May; 23(1):464. PubMed ID: 37208608
[TBL] [Abstract] [Full Text] [Related]
4. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of tumor-infiltrating CD163
Kinoshita J; Fushida S; Yamaguchi T; Moriyama H; Saito H; Shimada M; Terai S; Okamoto K; Nakamura K; Ninomiya I; Yagi S; Inaki N
BMC Cancer; 2022 Jun; 22(1):608. PubMed ID: 35658848
[TBL] [Abstract] [Full Text] [Related]
6. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
Wang Z; Wang X; Xu Y; Li J; Zhang X; Peng Z; Hu Y; Zhao X; Dong K; Zhang B; Gao C; Zhao X; Chen H; Cai J; Bai Y; Sun Y; Shen L
BMC Med; 2022 Apr; 20(1):133. PubMed ID: 35443723
[TBL] [Abstract] [Full Text] [Related]
7. Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in gastric cancer Patients.
Wang J; Kunzke T; Prade VM; Shen J; Buck A; Feuchtinger A; Haffner I; Luber B; Liu DHW; Langer R; Lordick F; Sun N; Walch A
Clin Cancer Res; 2022 Jul; 28(13):2865-2877. PubMed ID: 35395077
[TBL] [Abstract] [Full Text] [Related]
8. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.
Xing X; Shi J; Jia Y; Dou Y; Li Z; Dong B; Guo T; Cheng X; Li X; Du H; Hu Y; Jia S; Zhang J; Li Z; Ji J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361730
[TBL] [Abstract] [Full Text] [Related]
9. T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.
Christina Svensson M; Lindén A; Nygaard J; Borg D; Hedner C; Nodin B; Leandersson K; Jirström K
Oncoimmunology; 2021 May; 10(1):1921443. PubMed ID: 34104541
[TBL] [Abstract] [Full Text] [Related]
10. Intratumoral foxp3
Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
[TBL] [Abstract] [Full Text] [Related]
11. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
[TBL] [Abstract] [Full Text] [Related]
12. Pathological Complete Remission of Liver Metastases Correlates With Elimination of Tumor-infiltrating Tregs in gastric cancer.
Nakanishi Y; Hirota S; Hojo Y; Nakamura T; Kumamoto T; Kurahashi Y; Ishida Y; Shinohara H
Anticancer Res; 2021 Mar; 41(3):1571-1577. PubMed ID: 33788751
[TBL] [Abstract] [Full Text] [Related]
13. Immune Cell Landscape in gastric cancer.
Yang Y; He W; Wang ZR; Wang YJ; Li LL; Lu JZ; Tao Y; Zhang J; Fu SJ; Wang ZP; Liu SH
Biomed Res Int; 2021; 2021():1930706. PubMed ID: 33575321
[TBL] [Abstract] [Full Text] [Related]
14. Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.
Hasegawa S; Kobayashi N; Okubo N; Tokuhisa M; Goto A; Kurita Y; Sato T; Hosono K; Endo I; Nakajima A; Ichikawa Y
Intern Med; 2021 Apr; 60(7):977-983. PubMed ID: 33162477
[TBL] [Abstract] [Full Text] [Related]
15. Computational Image Analysis of T-Cell Infiltrates in Resectable gastric cancer: Association with Survival and Molecular Subtypes.
Challoner BR; von Loga K; Woolston A; Griffiths B; Sivamanoharan N; Semiannikova M; Newey A; Barber LJ; Mansfield D; Hewitt LC; Saito Y; Davarzani N; Starling N; Melcher A; Grabsch HI; Gerlinger M
J Natl Cancer Inst; 2021 Jan; 113(1):88-98. PubMed ID: 32324860
[TBL] [Abstract] [Full Text] [Related]
16. Blockade of β-Catenin-Induced CCL28 Suppresses gastric cancer Progression via Inhibition of Treg Cell Infiltration.
Ji L; Qian W; Gui L; Ji Z; Yin P; Lin GN; Wang Y; Ma B; Gao WQ
Cancer Res; 2020 May; 80(10):2004-2016. PubMed ID: 32156780
[TBL] [Abstract] [Full Text] [Related]
17. miR-133a-3p/foxp3 axis regulates cell proliferation and autophagy in gastric cancer.
Li JP; Zhang HM; Liu MJ; Xiang Y; Li H; Huang F; Li HH; Dai ZT; Gu CJ; Liao XH; Zhang TC
J Cell Biochem; 2020 Jun; 121(5-6):3392-3405. PubMed ID: 31904151
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer.
Park HS; Kwon WS; Park S; Jo E; Lim SJ; Lee CK; Lee JB; Jung M; Kim HS; Beom SH; Park JY; Kim TS; Chung HC; Rha SY
J Immunother Cancer; 2019 Oct; 7(1):268. PubMed ID: 31639056
[TBL] [Abstract] [Full Text] [Related]
19. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies.
Liu X; Xu D; Huang C; Guo Y; Wang S; Zhu C; Xu J; Zhang Z; Shen Y; Zhao W; Zhao G
J Transl Med; 2019 Jun; 17(1):192. PubMed ID: 31174544
[TBL] [Abstract] [Full Text] [Related]
20. PD-1
Kamada T; Togashi Y; Tay C; Ha D; Sasaki A; Nakamura Y; Sato E; Fukuoka S; Tada Y; Tanaka A; Morikawa H; Kawazoe A; Kinoshita T; Shitara K; Sakaguchi S; Nishikawa H
Proc Natl Acad Sci U S A; 2019 May; 116(20):9999-10008. PubMed ID: 31028147
[TBL] [Abstract] [Full Text] [Related]
[Next]
